UCL Establishes New Block Chain Subsidiary
TAMPA, FL–(Marketwired – December 18, 2017) – United Consortium Ltd. (OTC PINK: UCSO), an acquisition and development Company focused on creating shareholder value by identifying and monetizing opportunities in Technology, Internet, New Media and the Emerging Cannabis Space, today announced that it has formed its third wholly owned subsidiary Company called Block Chain, Inc. as it prepares to launch its new personal health records (PHR) block chain project in the first quarter of 2018.
UCL Chairman and Chief Executive Officer Scott Gallagher commented, “We believe block chain technology will disrupt much of business as we know it today. As we get deeper into building our personal health records (PHR) block chain business, it’s becoming clear that the solutions we create will have many uses in other industries. As a result we’re going to build a proprietary block chain library of our solutions that enables us to quickly deploy them in multiple industries. To facilitate our expansion into the Block Chain space, we’ve created Block Chain, Inc. as a wholly owned subsidiary of UCL.” Gallagher continued, “After detailed discussions with our partners regarding the Launch of our PHR Block Chain project we’re now able to set a firm launch date of Thursday, March 15, 2018.”
UCL is requesting that all interested Physicians preregister at www.PhysiciansBlockChain.com. UCL will be seeking feedback from Physicians prior to the beta launch expected in Q1 of 2018.
UCL is further requesting that patients seeking control of their Personal Health Records preregister at www.MyHealthBlockChain.com to interact with the Company during the beta launch as well.
About United Consortium Ltd. (UCL)
UCL is an acquisition and development Company focused on creating shareholder value by identifying and monetizing opportunities in Technology, Internet, New Media and the Emerging Cannabis Space. The Company is headquartered in Tampa, Florida. The most current information about the Company can be found on OTCMarkets.com or by visiting the Company’s website at www.UCLVentures.com.
This release contains forward-looking statements that relate to future events or United Consortium Ltd. (UCL’s) future performance or financial condition. Any statements that are not statements of historical fact, such as the statements above and including statements containing the words “plans,” “anticipates,” “expects” and similar expressions, should also be considered to be forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as result of a number of factors, including those described from time to time in United Consortium Ltd.’s filings with the Securities and Exchange Commission, OTC Markets or statement on the Companies websites. United Consortium Ltd. And all of its subsidiary companies undertakes no duty to update any forward-looking statements made herein.
For additional information contact: